Monoclonal Antibody to Urea Transporter, Erythrocyte (UTE)
| Code | Size | Price |
|---|
| MAE377Hu21-20ul | 20ul | £85.00 |
Quantity:
| MAE377Hu21-100ul | 100ul | £158.00 |
Quantity:
| MAE377Hu21-200ul | 200ul | £213.00 |
Quantity:
| MAE377Hu21-1ml | 1ml | £486.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Clonality: Monoclonal
Regulatory Status: RUO
Applications:
- Immunocytochemistry (ICC)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
SLC14A1; HUT11; HsT1341; JK; RACH1; UT-B1; UT1; Solute Carrier Family 14 Member 1,Urea Transporter,Kidd Blood Group
Buffer Formulation:
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Ig Isotype:
IgG1 Kappa
Immunogen:
CPE377Hu21-OVA Conjugated Urea Transporter, Erythrocyte (UTE)
Item Name:
Urea Transporter, Erythrocyte
Potency (Clone Number):
C4
Reactivity:
Po;
Source:
Monoclonal antibody preparation
Subcategory:
Monoclonal antibody preparation
USAGE:
Immunohistochemistry: 5-20ug/mL;
Immunocytochemistry: 5-20ug/mL;
Optimal working dilutions must be determined by end user.
Immunocytochemistry: 5-20ug/mL;
Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OVA Conjugated Urea Transporter, Erythrocyte (UTE) | CPE377Hu21 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||